Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Moskowitz Craig H. and Nademanee Auayporn and Masszi Tamás and Agura Edward and Holowiecki Jerzy and Abidi Muneer H. and Chen Andy I. and Stiff Patrick and Gianni Alessandro M. and Carella Angelo and Osmanov Dzhelil and Kollaborációs szervezet: AETHERA Study Group and Borbényi Zita and Illés Árpád and Masszi Tamás and Szomor Árpád (kollab. közrem.): Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.
LANCET, 385 (9980). pp. 1853-1862. ISSN 0140-6736 (2015)

[thumbnail of Moskowitz.pdf]
Preview
Text
Moskowitz.pdf - Published Version

Download (409kB) | Preview
Item Type: Journal Article
Szerzők száma: 99
Journal or Publication Title: LANCET
Date: 2015
Volume: 385
Number: 9980
Page Range: pp. 1853-1862
ISSN: 0140-6736
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 2914174
DOI azonosító: https://doi.org/10.1016/S0140-6736(15)60165-9
Date Deposited: 2022. Apr. 21. 13:22
Last Modified: 2022. Apr. 21. 13:22
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/24158
Web of Science® Times Cited: 506 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year